| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 133 |
| 1 | PREDNISONE | 45 |
| 2 | AMLODIPINE | 32 |
| 3 | LEVETIRACETAM | 32 |
| 4 | CARBAMAZEPINE | 30 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 30 |
| 6 | LEVETIRACETAM INJECTION | 30 |
| 7 | LEVETIRACETAM ORAL | 30 |
| 8 | ACETAMINOPHEN | 28 |
| 9 | METFORMIN | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUORIDE TOOTHPASTE | 1 | 0.0050 |
| 1 | EFGARTIGIMOD ALFA | 13 | 0.0033 |
| 2 | NAFTIFINE HYDROCHLORIDE | 1 | 0.0030 |
| 3 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 1 | 0.0027 |
| 4 | ECULIZUMAB | 133 | 0.0024 |
| 5 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 6 | PYRIDOSTIGMINE BROMIDE | 15 | 0.0020 |
| 7 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| 8 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 9 | AMIFAMPRIDINE PHOSPHATE | 4 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 133 |
| 1 | Corticosteroid [EPC] | 70 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 41 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 33 |
| 5 | Calcium Channel Blocker [EPC] | 32 |
| 6 | Mood Stabilizer [EPC] | 32 |
| 7 | beta-Adrenergic Blocker [EPC] | 31 |
| 8 | Proton Pump Inhibitor [EPC] | 29 |
| 9 | Interferon beta [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 13 | 0.0030 |
| 1 | Complement Inhibitor [EPC] | 133 | 0.0024 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 4 | 0.0008 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Complement 5a Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 8 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |